Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Moving Wedding Objections for Paramount Functions - 2‘Nahariya get ready’: Banner displaying Hezbollah threat mounted in Tehran’s Palestine Square
- 3Revvity says it will exceed 2025 profit forecast range
- 4Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling
- 5Most loved Caf\u00e9 Chain: Where Do You Get Your Caffeine Fix
- US FDA investigates Takeda's blood disorder drug after pediatric death
- Astrophotographer captures spectacular photo of Antennae Galaxies dueling in deep space
- 25 of the world’s best sandwiches
- Banks for High Fixed Store Rates: Amplify Your Reserve funds
- Former 'Bachelorette' welcomes 1st baby via emergency c-section
- Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- Mars orbiter sees 'butterfly' crater spread its wings on the Red Planet
- Extreme Manual for Picking a Camper Van
